Target Selection & Structural Coordinates
Select Pharmacological Protein-Ligand Complex
Complex:
Experimental Affinity:
pKd = 9.42
Kd = 0.38 nM
Gibbs Free Energy:
-12.85 kcal/mol
Exergonic (Spontaneous)
Pocket Interactions:
4 Hydrogen Bonds
BSA: 842 Ų
Class:
Kinase Inhibitor
ABL1 Kinase + Imatinib (PDB: 1FPU)
Click & drag to rotate 3D structure • Scroll to zoom • Right-click & drag to translate
Bound Ligand Small Molecule
LIGAND ID: Imatinib (STI-571)
FORMULA: C29 H31 N7 O
MOLECULAR WEIGHT: 493.6 g/mol
SMILES STRING: Cc1ccc(cc1Nc2nccc...
Binding Mechanism:
Type-II kinase inhibitor targeting the DFG-out inactive conformation, locking the activation loop in a catalytically inert state.
MM-GBSA Binding Free Energy ($\Delta G$) Decomposition
$\Delta G_{\text{bind}} = \Delta E_{\text{gas}} + \Delta G_{\text{solv}} - T \Delta S$
Thermodynamic Dissociation Constant ($K_d$) Spectrum
Picomolar ($pM$) to Micromolar ($\mu M$) potency benchmarking.
Exact Relation: $\Delta G = -RT \ln(10) \cdot pK_d \approx -1.3644 \cdot pK_d \text{ kcal/mol}$ at $298.15\text{ K}$.
Active Site Protein-Ligand Interaction Fingerprint (PLIF)
Key contact distances ($\text{\AA}$) and binding interaction types for critical pocket residues.
In-Silico Resistance Mutation Scanner ($\Delta\Delta G$)
Simulate point mutations in active site residues and predict loss of binding affinity.
Free Energy Shift ($\Delta\Delta G$)
+2.45 kcal/mol
Significant Destabilization
Affinity Fold Reduction
62.5x
Relative to Wild-Type
Clinical Phenotype
Drug Resistant Gatekeeper
Steric Clash in ATP Pocket
[Mechanism Analysis] In ABL1 kinase, Threonine 315 forms a critical water-mediated hydrogen bond with the pyridine nitrogen of Imatinib. The T315I mutation substitutes Threonine with bulky hydrophobic Isoleucine, creating an insurmountable steric clash that completely prevents Imatinib from binding without impairing the kinase's oncogenic catalytic activity.
Pharmacological Benchmark Complex Library
| PDB | Protein Target | Class | Bound Drug / Ligand | Experimental pKd | $\Delta G$ (kcal/mol) | Action |
|---|---|---|---|---|---|---|
| 1FPU | ABL1 Tyrosine Kinase | Kinase | Imatinib | 9.42 | -12.85 | |
| 2XYN | EGFR Kinase Domain | Kinase | Gefitinib | 8.85 | -12.07 | |
| 7L10 | SARS-CoV-2 Mpro | Viral Protease | Paxlovid (Nirmatrelvir) | 8.92 | -12.17 | |
| 3P0G | Beta-2 Adrenergic (ADRB2) | GPCR | BI-167107 | 9.15 | -12.48 | |
| 3MXF | BRD4 Bromodomain 1 | Epigenetic | (+)-JQ1 | 7.85 | -10.71 |